Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Phase IIa study of LAB CGRP begins enrollment

April 24, 2006

Positive results for CRx-170 in proof-of-concept asthma study

April 21, 2006

Recent patents report new treatment strategies for respiratory diseases

April 19, 2006

Fast track designation for SinuNase in chronic sinusitis

April 18, 2006

Schering-Plough selects compound from Pharmacopeia collaboration

April 13, 2006

Phase II study of Aridol for COPD completes enrollment

April 13, 2006

Forest and Almirall sign U.S. agreement for COPD treatment LAS-34273

April 12, 2006

Second approvable letter for Surfaxin

April 6, 2006

Novel agents for respiratory disorders disclosed in recent patents

April 6, 2006

PTC-124 shows pharmacological activity in CF patients with nonsense mutation

April 6, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...